Status:
COMPLETED
Combination Chemotherapy in Treating Young Adult Patients With Acute Lymphoblastic Leukemia
Lead Sponsor:
Gruppo Italiano Malattie EMatologiche dell'Adulto
Conditions:
Leukemia
Eligibility:
All Genders
18-34 years
Phase:
NA
Brief Summary
RATIONALE: Drugs used in chemotherapy work in different ways to stop the growth of cancer cells, either by killing the cells or by stopping them from dividing. Giving more than one drug (combination c...
Detailed Description
OBJECTIVES: * To determine the feasibility of combination chemotherapy in young adult patients with acute lymphoid leukemia. * To determine the complete response rate at the end of induction therapy ...
Eligibility Criteria
Inclusion
- DISEASE CHARACTERISTICS:
- Diagnosis of acute lymphoid leukemia, meeting any of the following criteria:
- Non-mature B-cell disease
- Non-Philadelphia chromosome positive disease
- T -cell or B-cell phenotype
- PATIENT CHARACTERISTICS:
- Not specified
- PRIOR CONCURRENT THERAPY:
- Prior pretreatment with antiblastic chemotherapy allowed
Exclusion
Key Trial Info
Start Date :
April 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 31 2017
Estimated Enrollment :
76 Patients enrolled
Trial Details
Trial ID
NCT01156883
Start Date
April 1 2010
End Date
October 31 2017
Last Update
September 13 2021
Active Locations (43)
Enter a location and click search to find clinical trials sorted by distance.
1
Complesso Ospedaliero S. Giovanni Addolorata
Roma, (RM), Italy, 00184
2
Azienda Ospedaliera - Nuovo Ospedale "Torrette"
Ancona, Italy
3
USL 8 - Ospedale S.Donato
Arezzo, Italy
4
Dipartimento Area Medica - Presidio Ospedaliero "C. e G.Mazzoni"
Ascoli Piceno, Italy